Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06673914 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

EFFECTS OF OLEUROPEIN ON BLOOD PARAMETERS AND INFLAMMATORY MARKERS IN ADULTS WITH METABOLIC SYNDROME

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated November 5, 2024 (before its estimated December 30, 2024 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
Atlas University
53 trials monitored
See all monitored trials
Obesity
3,874 trials monitored
See 152 trials at risk
The aim of this study is to determine the effect of 6 weeks supplementation of oleuropein on individuals diagnosed with metabolic syndrome. The baseline and end biochemical parameters and anthropometric measurements will be compared with control subjects.
Trial Details
NCT Number NCT06673914
Lead Sponsor Atlas University
Conditions
(from sponsor)		 Metabolic Syndrome, Insulin Resistance, Obesity, Abdominal, Obesity
Related terms Insulin Resistance, Metabolic Syndrome, Obesity, Obesity, Abdominal
Enrollment 34 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov